Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection.

Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection.
复制标题

DOI:
10.1016/j.cgh.2008.12.016
复制
发表时间:
2009-04
期刊:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子:
--
通讯作者:
AIDS Clinical Trials Group 5178 Study Group
AIDS Clinical Trials Group 5178 Study Group
中科院分区:
其他
文献类型:
--
作者:
Shire NJ;Rao MB;Succop P;Buncher CR;Andersen JA;Butt AA;Chung RT;Sherman KE;AIDS Clinical Trials Group 5178 Study Group

文献摘要

参考文献

相似文献

肝纤维化是丙型肝炎病毒(HCV)/HIV合并感染患者的一个重要问题。纤维化分期活检是准确的,但昂贵和侵入性。已经开发了几种利用非侵入性生物标志物的纤维化预测模型,但在合并感染患者中是次优的。我们比较了不同分期模型和有序回归与活检数据的结果。来自成人艾滋病临床试验组方案A5178的数据用于评估5种纤维化分期模型;评估受试者-操作者特征曲线下面积(AUROC)。用单变量回归评估个体协变量,然后进入有序逻辑回归模型,从中开发阶段指数。对173例患者的数据进行了评估; 85%的患者接受抗逆转录病毒治疗,31.2%的患者患有严重纤维化(F3/F4),14%的患者患有肝硬化(F4)。在有和没有F3/F4的患者之间观察到CD 4+细胞和血小板计数以及国际标准化比值的差异。在现有模型中,FIB-4指数表现最好,F4的特异性为88%,F3/F4的阴性预测值>86%,尽管AUROC值较低(F3/F4为0.56±0.03)。使用患者的人口统计学、临床和实验室数据,有序回归模型优于其他模型,AUROC = 0.85(SE 0.03)预测F3/F4期,AUROC = 0.89(SE 0.05)预测单独的3期。目前的非侵入性纤维化评估方法在HCV/HIV合并感染患者中的区分能力较差。有序回归分析优于其他非侵入性纤维化预测模型。配对活检的纵向研究将有助于改进有序回归指数。
Liver fibrosis is a significant concern for patients with hepatitis C virus (HCV)/HIV co-infection. Fibrosis staging by biopsy is accurate but costly and invasive. Several fibrosis prediction models utilizing non-invasive biomarkers have been developed but are suboptimal in co-infected patients. We compared results from different staging models and ordinal regression with biopsy data. Data from the Adult AIDS Clinical Trials Group protocol A5178 were used to evaluate 5 models of fibrosis staging; areas under receiver-operator characteristic curves (AUROC) were assessed. Individual covariates were assessed with univariable regression then entered into an ordinal logistic regression model from which a stage-wise index was developed. Data from 173 patients were evaluated; 85% were on anti-retroviral therapy, 31.2% had severe fibrosis (F3/F4) and 14% had cirrhosis (F4). Differences in CD4+ cell and platelets counts and international normalized ratio values were observed between those with and without F3/F4. Among existing models, the FIB-4 index performed best, with 88% specificity for F4 and >86% negative predictive values for F3/F4, although AUROC values were low (0.56±0.03 for F3/F4). Using patients’ demographic, clinical, and laboratory data, the ordinal regression model outperformed others, with AUROC = 0.85 (SE 0.03) for predicting stage F3/F4 and 0.89 (SE 0.05) for stage 3 alone. Current noninvasive methods of fibrosis assessment have poor discriminatory capacity in HCV/HIV co-infected patients. Ordinal regression analysis outperformed other non-invasive fibrosis prediction models. Longitudinal studies with paired biopsies will assist in refining the ordinal regression index.
DOI: 10.1186/1476-5926-3-8
发表时间: 2004-09-23
期刊: Comparative hepatology
影响因子: --
作者:
Poynard T;Imbert-Bismut F;Munteanu M;Messous D;Myers RP;Thabut D;Ratziu V;Mercadier A;Benhamou Y;Hainque B
通讯作者: Hainque B
DOI: 10.1016/j.jhep.2005.02.025
发表时间: 2005-07-01
影响因子: 25.7
作者:
Kelleher, TB;Mehta, SH;Afdhal, NH
通讯作者: Afdhal, NH
DOI: 10.1097/00002030-200303280-00010
发表时间: 2003-03-28
期刊: AIDS
影响因子: 3.8
作者:
Myers, RP;Benhamou, Y;Poynard, T
通讯作者: Poynard, T
DOI: 10.1373/49.3.450
发表时间: 2003-03-01
期刊: CLINICAL CHEMISTRY
影响因子: 9.3
作者:
Rossi, E;Adams, L;Jeffrey, G
通讯作者: Jeffrey, G
DOI: 10.1002/hep.20717
发表时间: 2005-06-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Lackner, C;Struber, G;Stauber, RE
通讯作者: Stauber, RE